Rigorous research in one digital platform
A clinically validated, end-to-end platform for digital trials and multimodal data collection at scale.
Combining academic rigour with real-world usability to power studies and trials.
The juli platform allows fully customisable clinical, behavioural, and epidemiological studies and trials. It has already powered multiple peer-reviewed studies and engaged over 30,000 users across 40+ countries.
The advantages of juli
Flexible and fast setup
Rapid costing, study design, and onboarding, with editable measures, interventions, and components deployable in weeks
High retention, real engagement
Co-designed with participants, researchers, and clinicians to deliver 7–10x longer retention than average health apps
Compliant and
ethics-ready
Fully GDPR, HIPAA, and SOC 2 aligned and ethics-ready with transparent data ownership and de-identified exports
All-in-one platform
Capture extensive multimodal data alongside full study management tools, participant engagement features, and expert support
Award winning:
Engagement - the holy grail of health apps
Downloading health apps isn’t enough to drive impact. Users need to see a benefit, be engaged and stay interested enough to actually use them. Easier said than done; most apps and especially health apps struggle to achieve user engagement and retention.
Retention of juli users after 30 days. (Industry average: 3.7%)
Engagement: More than half of the active juli users use the app at least twice per week.
